Kai Yi Wu MD , Ruochen Mao MD , Craig Butler MD, MS , Pishoy Gouda MBBCh BAO, MS , Naji Alhulaimi MBBS , Rohan Parab MD , Bryan James Dicken MD, MS , Sayra Khandekar MD , Michelle Graham MD , Kevin R. Bainey MD, MS
{"title":"Stellate Ganglion Block and Bilateral Sympathectomy for Recurrent Coronary Vasospasm Secondary to Severe Eosinophilic Asthma","authors":"Kai Yi Wu MD , Ruochen Mao MD , Craig Butler MD, MS , Pishoy Gouda MBBCh BAO, MS , Naji Alhulaimi MBBS , Rohan Parab MD , Bryan James Dicken MD, MS , Sayra Khandekar MD , Michelle Graham MD , Kevin R. Bainey MD, MS","doi":"10.1016/j.jaccas.2024.102813","DOIUrl":null,"url":null,"abstract":"<div><div>A 42-year-old man experienced recurrent coronary artery spasm (CAS) secondary to eosinophilic asthma despite being on multiple medications. He underwent a successful unilateral stellate ganglion block followed by bilateral thoracoscopic sympathectomy, with no subsequent recurrence of CAS. These invasive therapies offer a potential treatment option for refractory CAS.</div></div>","PeriodicalId":14792,"journal":{"name":"JACC. Case reports","volume":"30 2","pages":"Article 102813"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11775813/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Case reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266608492400874X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
A 42-year-old man experienced recurrent coronary artery spasm (CAS) secondary to eosinophilic asthma despite being on multiple medications. He underwent a successful unilateral stellate ganglion block followed by bilateral thoracoscopic sympathectomy, with no subsequent recurrence of CAS. These invasive therapies offer a potential treatment option for refractory CAS.